EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in Gene Therapy for Age-Related Macular Degeneration: A Narrative Review

Noor-Us-Sabah Ahmad iD, Tahreem A Mir

Journal of Clinical Medicine · 18.04.2026 · 15 (8) · 3097

DOI: 10.3390/jcm15083097 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 18.04.2026. Verfasst von Noor-Us-Sabah Ahmad und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and Visual Sciences, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Age-related macular degeneration (AMD) is the most common cause of blindness and vision impairment in individuals over 60 years of age in the United States (US). Despite this, current treatment options have limitations related to drug efficacy and durability. Gene therapy provides a potential solution by providing a more durable and longer- acting treatment option that can decrease treatment burden and improve long-term visual outcomes. This review presents the current treatment approaches, routes of administration, and vectors being investigated for gene therapy delivery in AMD. It also provides an update on the ongoing gene therapy clinical trials for dry and wet AMD. As these therapies advance into later-stage clinical trials, ophthalmologists need to be mindful of the many challenges pertaining to gene therapy delivery, including safety, limitations related to immunogenicity, long-term ocular and systemic side effects, and potential barriers to drug manufacturing and access. Continued efforts are required to improve precision, safety, and efficacy, including identifying the safest and most effective vectors and delivery routes, and minimizing potential adverse effects. In addition, guidelines need to be established to guide appropriate patient selection before gene therapy can be integrated into clinical practice.

Schlagwörter

Stichwörter der Autor:innen

age-related macular degenerationgene therapyneovascular age-related macular degenerationvascular endothelial growth factorviral vectors

Autor:innen und Institutionen

  • Department of Ophthalmology and Visual Sciences, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
  • Institute for Vision Research, University of Iowa, Iowa City, IA 52242, USA.

ORCID-Profile: Noor-Us-Sabah Ahmad

Zitieren

APA

Ahmad, N. U., & Mir, T. A. (2026). Advances in Gene Therapy for Age-Related Macular Degeneration: A Narrative Review. Journal of Clinical Medicine, 15(8), 3097. https://doi.org/10.3390/jcm15083097

Vancouver

Ahmad NU, Mir TA. Advances in Gene Therapy for Age-Related Macular Degeneration: A Narrative Review. Journal of Clinical Medicine. 2026;15(8):3097. doi:10.3390/jcm15083097

BibTeX
@article{Ahmad2026,
  author = {Ahmad, Noor-Us-Sabah and Mir, Tahreem A},
  title = {Advances in Gene Therapy for Age-Related Macular Degeneration: A Narrative Review},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {8},
  pages = {3097},
  doi = {10.3390/jcm15083097}
}
Kostenlos starten →